The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
The role of the D 2 dopamine receptor (D 2 R) in A 2A adenosine receptor (A 2A R)-mediated behavioral and cellular responses as revealed by A 2A and D 2 receptor knockout mice
Open accessAbstract
The A 2A R is largely coexpressed with D 2 Rs and enkephalin mRNA in the striatum where it modulates dopaminergic activity. Activation of the A 2A R antagonizes D 2 R-mediated behavioral and neurochemical effects in the basal ganglia through a mechanism that may involve direct A 2A R–D 2 R interaction. However, whether the D 2 R is required for the A 2A R to exert its neural function is an open question. In this study, we examined the role of D 2 Rs in A 2A R-induced behavioral and cellular responses, by using genetic knockout (KO) models (mice deficient in A 2A Rs or D 2 Rs or both). Behavioral analysis shows that the A 2A R agonist 2–4-(2-carboxyethyl)phenethylamino-5′- N -ethylcarboxamidoadenosine reduced spontaneous as well as amphetamine-induced locomotion in both D 2 KO and wild-type mice. Conversely, the nonselective adenosine antagonist caffeine and the A 2A R antagonist 8-(3-chlorostyryl)caffeine produced motor stimulation in mice lacking the D 2 R, although the stimulation was significantly attentuated. At the cellular level, A 2A R inactivation counteracted the increase in enkephalin expression in striatopallidal neurons caused by D 2 R deficiency. Consistent with the D 2 KO phenotype, A 2A R inactivation partially reversed both acute D 2 R antagonist (haloperidol)-induced catalepsy and chronic haloperidol-induced enkephalin mRNA expression. Together, these results demonstrate that A 2A Rs elicit behavioral and cellular responses despite either the genetic deficiency or pharmacological blockade of D 2 Rs. Thus, A 2A R-mediated neural functions are partially independent of D 2 Rs. Moreover, endogenous adenosine acting at striatal A 2A Rs may be most accurately viewed as a facilitative modulator of striatal neuronal activity rather than simply as an inhibitory modulator of D 2 R neurotransmission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624
Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., & Patel, Y. C. (2000) · Science · doi:10.1126/science.288.5463.154 · Cited by 888
Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia
Ferré, S., Fuxe, K., B. Fredholm, B., Morelli, M., & Popoli, P. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01096-5 · Cited by 824
Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice
Simpson, E. M., Linder, C. C., Sargent, E. E., Davisson, M. T., Mobraaten, L. E., & Sharp, J. J. (1997) · Nature Genetics · doi:10.1038/ng0597-19 · Cited by 686
Fink, J. S., Weaver, D. R., Rivkees, S. A., Peterfreund, R. A., Pollack, A. E., Adler, E. M., & Reppert, S. M. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90173-9 · Cited by 650
Self-citationA2AAdenosine Receptor Deficiency Attenuates Brain Injury Induced by Transient Focal Ischemia in Mice
Chen, J.-F., Huang, Z., Ma, J., Zhu, J., Moratalla, R., Standaert, D., Moskowitz, M. A., Fink, J. S., & Schwarzschild, M. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09192.1999 · Cited by 557
Self-citationFerre, S., von Euler, G., Johansson, B., Fredholm, B. B., & Fuxe, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7238 · Cited by 552
Distribution, biochemistry and function of striatal adenosine A2A receptors
Svenningsson, P. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00011-8 · Cited by 516
Kelly, M. A., Rubinstein, M., Phillips, T. J., Lessov, C. N., Burkhart-Kasch, S., Zhang, G., Bunzow, J. R., Fang, Y., Gerhardt, G. A., Grandy, D. K., et al. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03470.1998 · Cited by 447
Self-citationKelly, M. A., Rubinstein, M., Asa, S. L., Zhang, G., Saez, C., Bunzow, J. R., Allen, R. G., Hnasko, R., Ben-Jonathan, N., Grandy, D. K., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80351-7 · Cited by 426
Self-citation
Cited by
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Linden, J., & Müller, C. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003285 · Cited by 1,301
Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits
Salamone, J. D., Correa, M., Farrar, A., & Mingote, S. M. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0668-9 · Cited by 1,000
Fredholm, B. B., Chen, J.-F., Cunha, R. A., Svenningsson, P., & Vaugeois, J.-M. (2005) · International Review of Neurobiology · doi:10.1016/s0074-7742(05)63007-3 · Cited by 692
Self-citationCaffeine as a psychomotor stimulant: mechanism of action
Fisone, G., Borgkvist, A., & Usiello, A. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3269-3 · Cited by 538
Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome
Evans, A. H., Katzenschlager, R., Paviour, D., O'Sullivan, J. D., Appel, S., Lawrence, A. D., & Lees, A. J. (2004) · Movement Disorders · doi:10.1002/mds.20045 · Cited by 474
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine
Felger, J. C., & Treadway, M. T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 442
Targeting adenosine A2A receptors in Parkinson's disease
Schwarzschild, M. A., Agnati, L., Fuxe, K., Chen, J.-F., & Morelli, M. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.09.004 · Cited by 433
Self-citationImaging the Role of Inflammation in Mood and Anxiety-related Disorders
Felger, J. C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171123201142 · Cited by 427
Purinergic signalling: From normal behaviour to pathological brain function
Burnstock, G., Krügel, U., Abbracchio, M. P., & Illes, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.006 · Cited by 397
ACTIONS OF ADENOSINE AT ITS RECEPTORS IN THE CNS: Insights from Knockouts and Drugs
Fredholm, B. B., Chen, J.-F., Masino, S. A., & Vaugeois, J.-M. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095731 · Cited by 354
Self-citationAgnati, L. F., Ferré, S., Lluis, C., Franco, R., & Fuxe, K. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.2 · Cited by 323
Dopamine Dysregulation Syndrome: An Overview of its Epidemiology, Mechanisms and Management
OʼSullivan, S. S., Evans, A. H., & Lees, A. J. (2009) · CNS Drugs · doi:10.2165/00023210-200923020-00005 · Cited by 265
Ferré, S., Bonaventura, J., Zhu, W., Hatcher-Solis, C., Taura, J., Quiroz, C., Cai, N.-S., Moreno, E., Casadó-Anguera, V., Kravitz, A. V., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00243 · Cited by 100
“This was followed by behavioral studies with genetic inactivation of A2AR and D2R, which stressed the value of the canonical interaction, which was assumed to be independent of intermolecular interactions between A2AR and D2R (Chen et al., 2001).”
BackgroundResultZachariou, V., Benoit-Marand, M., Allen, P. B., Ingrassia, P., Fienberg, A. A., Gonon, F., Greengard, P., & Picciotto, M. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01318-x · Cited by 84
Metadata
- Authors
- Chen, J.-F., Moratalla, R., Impagnatiello, F., Grandy, D. K., Cuellar, B., Rubinstein, M., Beilstein, M. A., Hackett, E., Fink, J. S., Low, M. J., Ongini, E., & Schwarzschild, M. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-02-13
- Volume
- 98
- Issue
- 4
- Pages
- 1970-1975
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2092666379
- Cited by
- 256
- References
- 40
- FWCI
- 8.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.